Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Westfield, New York Clinical Trials

A listing of Westfield, New York clinical trials actively recruiting patient volunteers.

RESULTS

Found (6) clinical trials

A Research Study to Show the Effect of Aprocitentan in the Treatment of Difficult to Control (Resistant) High Blood Pressure (Hypertension) and Find Out More About Its Safety

The purpose of the study is to show the blood pressure lowering effect of aprocitentan, a new drug, when added to other anti-hypertensive drugs of patients with difficult to control (resistant) high blood pressure (hypertension), and to show that blood pressure reduction is kept for long period of time.

Phase

0.0 miles

Learn More »

Semaglutide Effects on Heart Disease and Stroke in Patients With Overweight or Obesity

The researchers are doing the study to see if semaglutide may reduce the risk of having cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. The participant will either get semaglutide (active medicine) or placebo ("dummy" medicine). Which treatment the participants get is decided by chance. ...

Phase

0.0 miles

Learn More »

A global registry to study the demographics, socioeconomic and clinical factors, etiologies, pathophysiology, management, barriers to care, and outcomes of heart failure patients.

Phase N/A

0.28 miles

Learn More »

To demonstrate the analgesic efficacy of PEMF treatment compared to sham treatment in patients with painful diabetic distal peripheral neuropathy when treatment is administered 30 minutes twice daily.

Phase N/A

0.28 miles

Learn More »

The purpose of the study is to show that aprocitentan, a new study drug, can lower the blood pressure of subjects with difficult to control (resistant) high blood pressure (hypertension) and keep the reduction for long period of time. The purpose is also to see if aprocitentan is safe for ...

Phase

0.28 miles

Learn More »

This study will look mainly at the effect of semaglutide on cardiovascular events in patients with overweight or obesity and with prior cardiovascular disease. Approximately 17,500 men and women across the world will take part in this study.  

Phase N/A

0.28 miles

Learn More »